Curex vs Nectar: Which At-Home Allergy Drop Service Is Right for You?

Quick Answer

Curex and Nectar both charge $99/month for self-pay patients, but they differ fundamentally in clinical philosophy. Nectar focuses on your top 1–2 allergens at higher concentrations with the strongest clinical advisory team in the space (Harvard, OHSU, EAACI advisors). Curex treats 5–7 allergens simultaneously, accepts ages 5+, and is the only provider billing insurance (from $39/month). Your choice depends on whether you prioritize clinical pedigree and concentration or insurance savings and broader allergen coverage.

Quick Facts

Detail	Info
Monthly cost	Both $99/month self-pay; Curex from $39/month with insurance; Nectar test from $79 vs Curex $199 (2026)
Clinical team	Nectar: Dr. Tania Elliott (CMO), Dr. Shyam Joshi (CSO/OHSU), advisors Dr. Kari Nadeau (Harvard), Dr. Mohamed Shamji (EAACI)
Pharmacy model	Nectar: vertically integrated, in-house pharmacy. Curex: partners with Allergychoices
Allergen approach	Nectar: top 1–2 allergens, higher concentration. Curex: 5–7 allergens simultaneously
Ages served	Curex: 5+. Nectar: adults 18+ only
Funding	Nectar: $24M+ raised. Curex: undisclosed

"Curex or Nectar — Which One Is Actually Better?"

You've decided on at-home allergy drops. Now you're comparing providers, and Curex and Nectar look similar on the surface: same price, same concept, delivered to your door. But their approaches to treatment are almost opposite.

Nectar's website features a medical advisory board that reads like an allergy research all-star roster. Curex's website emphasizes insurance billing and treating the whole family. One prioritizes clinical credibility, the other accessibility.

The deeper you look, the more the differences reveal themselves — in how they formulate your drops, who oversees your treatment, and what trade-offs each model creates. Neither is wrong. They're solving different problems for different patients.

Why the Differences Matter

Step 1 — Nectar's clinical bench is unmatched in the DTC space. Dr. Tania Elliott serves as CMO, Dr. Shyam Joshi (OHSU faculty) as Chief Scientific Officer, with advisory board members including Dr. Kari Nadeau of Harvard (a leading immunotherapy researcher) and Dr. Mohamed Shamji, president of the EAACI Immunology Section. No other at-home provider has this depth of academic involvement. Nectar is also the only provider that is vertically integrated — manufacturing drops in their own pharmacy rather than outsourcing to compounding partners.

Step 2 — The treatment philosophy diverges sharply. Nectar focuses on your top 1–2 dominant allergens and treats them at higher concentrations, claiming "allergen levels equivalent to FDA-approved products." This mirrors the FDA tablet approach (single-allergen, standardized dosing) translated to drops. Curex treats 5–7 allergens simultaneously in a multi-allergen formula through its Allergychoices partnership (50+ years, 300,000+ patients). The multi-allergen approach is more common in US SLIT practice; the focused approach has stronger parallels to the evidence base behind FDA-approved tablets.

Step 3 — Accessibility and trust signals diverge too. Curex serves patients age 5+ in 44 states — the only major provider for children. Nectar is adults 18+ only, available in approximately 44 states. On trust metrics: Curex has a BBB "C" rating with 54 complaints; Nectar has only 1 Trustpilot review (negative), reflecting its newer market presence. 🚩 Nectar's limited review footprint means less consumer data to evaluate — strong clinical advisors don't automatically equal strong customer experience. Curex's larger complaint volume reflects both higher patient volume and documented operational issues.

What To Do Next

1. Determine your age and insurance eligibility first. If you're seeking treatment for a child, Curex is your only option between these two — Nectar serves adults only. If you have insurance that covers SLIT, Curex at $39/month saves $720/year over Nectar's $99.

2. Consider your allergen profile. If you have one dominant allergen driving most of your symptoms (e.g., dust mites or cat dander), Nectar's focused, higher-concentration approach may be more targeted. If you react to trees, grasses, dust mites, and mold, Curex's multi-allergen formula addresses more triggers simultaneously.

3. A free allergy quiz identifies your dominant allergens and insurance options. This helps you determine whether a focused or broad treatment approach fits your specific sensitization pattern — before committing to either provider.

When Nectar Is the Stronger Choice

Nectar's model makes the most sense if you're an adult with 1–2 dominant allergens, you're paying out of pocket (no insurance advantage for Curex), and clinical pedigree matters to you. Their in-house pharmacy removes a link in the supply chain — your drops are formulated and shipped from the same facility, reducing handling variability.

The $24M+ in funding also signals institutional confidence and runway to invest in clinical validation. If Nectar publishes outcomes data from their own patient cohort (not yet available as of March 2026), they could become the first DTC provider with proprietary efficacy evidence.

However, if you need to treat a child, want insurance billing, or have 4+ significant allergens, Nectar's model doesn't serve you. And with only 1 public review, you're taking a customer-experience bet that Curex's 54 BBB complaints — for all their negativity — at least let you evaluate. ⚠️ Nectar's limited track record is a neutral data point, not a red flag, but it means less accountability evidence.

Related Issues to Check

• Curex vs Wyndly comparison — If Nectar's adults-only restriction excludes you, or you want a provider with a 90-day money-back guarantee, Wyndly offers a third option with the cleanest regulatory record in the space.

• Best at-home allergy immunotherapy 2026 — All five major providers compared side-by-side: Curex, Wyndly, Nectar, Quello, and HeyAllergy. Includes pricing, testing methods, state coverage, and trust metrics.

• How sublingual immunotherapy works — Understanding the immune mechanism helps you evaluate whether Nectar's focused approach or Curex's multi-allergen approach better matches the evidence on sublingual tolerance induction.

Frequently Asked Questions

Why does Nectar focus on only 1–2 allergens? Nectar's approach mirrors the FDA-approved SLIT tablet model: single-allergen, standardized-dose treatment with the strongest clinical evidence base. By concentrating on your dominant triggers at higher doses, they aim to replicate the efficacy profile of tablets like Grastek and Odactra using custom drops. The trade-off is leaving secondary allergens untreated.

Is Nectar's in-house pharmacy better than Curex's compounding partner? Vertical integration means Nectar controls formulation quality end-to-end. Curex partners with Allergychoices, which has 50+ years of compounding experience and 300,000+ patients — a track record no in-house startup pharmacy can match yet. Both models have advantages; neither is inherently safer.

Can I use Nectar's $79 test and then choose a different provider? Nectar's allergy test ($79) is among the cheapest available. The results are standard IgE values that any provider could use. However, another provider may want their own testing to confirm or expand the panel. Curex's test ($199) covers 60+ allergens via ImmunoCAP venous draw.

Which provider has better outcomes data? Neither publishes proprietary patient outcomes as of March 2026. Curex cites Allergychoices' network data (300,000+ patients over 50+ years). Nectar cites the broader SLIT evidence base and their FDA-equivalent dosing approach. Both rely on the published immunotherapy literature rather than their own clinical trials.

What if I want to switch from one to the other? Switching is straightforward. Both use sublingual drops, and transitioning doesn't require restarting from zero. Your new provider will review your allergen profile and may reformulate — Nectar would narrow your formula, Curex would broaden it.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Not Sure Which Provider Fits?

A 3-minute allergy quiz identifies your dominant allergens, checks your insurance eligibility, and shows which provider model — focused or broad — matches your profile.

Take the free 3-minute allergy quiz →